Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
IOLCP.NS
Strong BuyPremium GrowerIOL Chemicals and Pharmaceuticals Limited · Healthcare · India · $653M · Avg Vol: $10M/d
89
StockRankGet insider-trade alerts
Q
67
V
32
M
90
P/E (TTM)
36.6x
ROE
7.7%
D/E
0.1x
Dividend %
0.5%
COMPANY DESCRIPTION
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. It operates through two segments: Pharmaceuticals and Specialty Chemicals.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.0B | 21.2B | 20.7B | 23.1B | 1.6% | 25.3B | 27.3B | 31.4B | 16.6% |
| EPS (INR) | 4.74 | 4.58 | 3.44 | 4.69 | -0.4% | 5.74 | 7.07 | — | 50.8% |
| Shares | 293.5M | 293.5M | 293.5M | 293.5M | 0.0% | 293.5M | — | — | — |
| Debt | 798.1M | 327.6M | 1.2B | 1.4B | 19.3% | 1.4B | — | — | — |
| Equity | 15.1B | 16.1B | 16.9B | 18.0B | 6.1% | — | — | — | — |
| Op CF | 1.2B | 2.9B | 1.8B | 2.1B | 20.6% | 2.2B | — | — | — |
| Inv CF | -1.2B | -1.9B | -1.5B | -2.0B | — | — | — | — | — |
| Fin CF | -41.1M | -925.0M | 460.4M | -290.3M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+44.7%
SMA 50SMA 200
Close
$2.19
RSI (14)
84.0
52W High
$2.30
From 52W High
1.0%
SCORE BREAKDOWN
Quality
67
ROIC
12.6%77.8
ROE
7.7%63.3
GP/Assets
34.5%70.4
Op. Margin
10.9%64.8
FCF/Assets
1.6%53.2
Piotroski
783.9
Int. Cover
17.2x69.5
D/E Ratio
0.08x66.4
Current Ratio
1.78x34.0
Value
32
P/E (TTM)
36.6x32.6
EV/EBITDA
19.7x35.3
P/FCF
150.3x11.2
P/B
3.4x41.2
P/S
2.4x62.8
Div Yield
0.5%14.6
Momentum
90
52W High %
96%95.5
RS 6M
196%99.4
SMA 50/200
1.51x98.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+70%64.8
Q Growth
90%82.4
FUNDAMENTALS
Market Cap
$653M
P/E (Forward)
21.6x
Gross Margin
35.4%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of IOLCP.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| IOLCP.NS | IOL Chemicals and Pharmaceuticals Limited(you) | $653M | 89 | Strong Buy |
| SPARC.NS | Sun Pharma Advanced Research Company Limited | $696M | 89 | Strong Buy |
| MOREPENLAB.NS | Morepen Laboratories Limited | $677M | 85 | Strong Buy |
| BLISSGVS.NS | Bliss GVS Pharma Limited | $810M | 88 | Strong Buy |
| INNOVACAP.NS | Innova Captab Limited | $707M | 79 | Buy |
| UNICHEMLAB.NS | Unichem Laboratories Limited | $413M | 87 | Strong Buy |
| PGHL.NS | Procter & Gamble Health Limited | $981M | 93 | Strong Buy |
| VIYASH.NS | Viyash Scientific Limited | $1.2B | 88 | Strong Buy |
| FDC.NS | FDC Limited | $594M | 77 | Buy |
| STAR.NS | Strides Pharma Science Limited | $1.2B | 93 | Strong Buy |
Peer medians: ROE 11.9% · P/E 42.8x · Gross margin 59.4%